2m 2m 2m 2m 2m 2m 2m
InflaRx (IFRX)
NASDAQ
$2.07-$0.03 (-1.43%)
Price as of Aug 21, 2026 6:31 PM EDT- $124.6MMarket Cap
- 129.89%1-Year Change
- BiotechnologyIndustry
InflaRx (IFRX)
$2.07-$0.03 (-1.43%)
IFRX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $2.10 | ||
Change | +$0.08 (+3.96%) | ||
Open | $2.03 | ||
High | $2.12 | ||
Low | $2.02 | ||
Previous Close | $2.02 | ||
Volume | 419,898 | ||
30-Day Average Volume | 882,781 | ||
1-Week Change | 2.94% | ||
1-Month Change | 16.02% | ||
1-Year Change | 129.89% | ||
3-Year Change | -38.78% | ||
5-Year Change | -8.70% | ||
Fundamentals | |||
Shares Outstanding | 59.4M | ||
Total Assets | $55.2M | ||
Market Cap | $124.6M | ||
Enterprise Value | $108.6M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | N/A | ||
Free Cash Flow | N/A | ||
EBIT | N/A | ||
EBITDA | N/A | ||
Net Working Capital | N/A | ||
EPS | N/A | ||
Enterprise Value/EBITDA | N/A | ||
Enterprise Value/Revenue | N/A | ||
P/B | N/A | ||
P/E | N/A | ||
PEG | N/A | ||
Price/Free Cash Flow | N/A | ||
Price/Operating Cash Flow | N/A | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue